HomeLearn › Weight-Loss Shots
Learn · Weight

Weight-loss shots & pills, explained

A woman laughing while chopping fresh vegetables

Semaglutide, tirzepatide, shots, pills — the words get used interchangeably and they are not the same thing. Here is what each one actually is, straight from the FDA labels.

General information, not medical advice · A medical provider licensed in your state makes every medical decision

Reviewed against primary sources. Every clinical claim below is checked against FDA labeling, clinical-society guidelines, or peer-reviewed literature — 5 sources cited, last reviewed 2026-07-15.
← All guides

Weight loss shots are the everyday name for a group of prescription medications called GLP-1s, and if you've heard friends, headlines, or your group chat buzzing about them, this is your plain-language starting point. Below we explain what these weight loss injections and pills actually are, the difference between the two main options, and what to know before you consider whether they're right for you. This is education, not a prescription — a licensed clinician always makes the medical call.

You may have seen the term "skinny shot" floating around online. We don't love that framing, because these are real medications with real effects and real side effects — not a shortcut or a promise. So let's trade the hype for clarity.

What is a GLP-1 medication?

Semaglutide — the active ingredient in Wegovy® and Ozempic® — operates as a GLP-1 receptor agonist.[1] It works by activating GLP-1 receptors primarily located in the gastrointestinal tract, pancreas, and brain.[1] Semaglutide lowers blood glucose levels and promotes weight loss by activating those receptors.[1] That's the science behind "what is GLP-1."

What is the weight-loss shot called?

There isn't just one. For chronic weight management, semaglutide is the active ingredient in the FDA-approved medication Wegovy®, and tirzepatide is the active ingredient in the FDA-approved medication Zepbound®. Semaglutide is also marketed as Ozempic® and as oral tablets under the brand Rybelsus®. "Weight loss injections" usually refers to these. Which one a clinician considers depends on your health history, goals, and medical eligibility.

Are weight-loss injections better than pills?

Neither is universally "better" — they suit different people. For chronic weight management, semaglutide is administered through weekly subcutaneous self-injections.[1] Semaglutide is also available as oral tablets, which are taken daily.[1] Tirzepatide is administered via the subcutaneous route once weekly and is not yet available in an oral form.[4] Effectiveness, side effects, dosing, and availability differ. Individual results vary, and the right format is a conversation to have with a licensed clinician.

What's the difference between semaglutide and tirzepatide?

Tirzepatide is a dual agonist for the glucagon-like peptide-1 (GLP-1) and GIP receptors.[5] Semaglutide operates as a GLP-1 receptor agonist.[1] Tirzepatide's dual agonism at the GIP and GLP-1 receptors reduces the patient's appetite.[4] Tirzepatide works similarly to GLP-1 medications but with greater efficacy.[4] That's a general finding, not a promise for any one person — tolerability and health history still shape what a clinician considers. Our explainer on semaglutide vs tirzepatide digs deeper.

Do you need a prescription for weight-loss shots?

Yes. The FDA advises that patients should only obtain drugs containing semaglutide with a prescription from a licensed health care provider.[1] These are prescription medications: a licensed clinician must review your health history, screen for contraindications, and decide whether treatment is appropriate. Anyone offering these without a medical evaluation should be a red flag — prescribing is a clinical decision, not a shopping cart.

How do weight loss shots actually help with weight?

Semaglutide slows gastric emptying and contributes to an overall reduction in appetite.[1] Its interaction with GLP-1 receptors in the hypothalamus may also mitigate sensations of hunger, alleviate food cravings, and enhance the feelings of satiety.[1] The recommended approach for weight management integrates semaglutide with a balanced diet and regular exercise. They are tools, not magic — and outcomes depend on the person, the plan, and consistency. Individual results vary.

What about side effects?

Honesty matters here. For tirzepatide, the most commonly reported adverse effects are gastrointestinal, including nausea, vomiting, and diarrhea, and constipation has also been reported in some users.[4] With semaglutide, the lower initial dose for both the weekly injection and the daily tablet aims to mitigate gastrointestinal symptoms[1], and it is essential to follow dose escalation instructions to reduce the risk of gastrointestinal adverse events. More serious risks exist. Acute pancreatitis is a known risk of tirzepatide.[4] For tirzepatide, the risk level for acute pancreatitis is similar to that of GLP-1 agonist medications.[4] The FDA-approved labeling for semaglutide in weight management carries a boxed warning about the risk of thyroid C-cell tumors.[2] That same FDA-approved labeling contraindicates semaglutide for chronic weight management in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2.[2] These medications are not appropriate for everyone, which is why a licensed clinician screens for contraindications before prescribing. We cover this more in are weight-loss shots safe.

A note on compounded medications

You may see "compounded semaglutide" or "compounded tirzepatide" offered online. Compounded medications are not FDA-approved. They are prepared in FDA-regulated facilities by state-licensed pharmacies when a licensed clinician determines they're appropriate for a patient. A compounded preparation is a distinct product from any brand-name medication, and it should never be marketed as equivalent to one. If a clinician prescribes a compounded option, understanding what that means is part of informed care.

Where do I start?

If you're curious whether a GLP-1 medication fits your situation, the first step is a medical evaluation — not self-diagnosis. You can learn more about the process and eligibility through our weight wellness overview, where an intake connects you with our medical provider partner for a clinical review. There's no obligation, and no one can promise you a result before knowing your health story.

The bottom line: semaglutide is a real prescription medication that contributes to an overall reduction in appetite. It isn't a "skinny shot" fantasy, and these medications aren't for everyone. Get the facts, ask questions, and let a licensed clinician help you decide.

FAQ

Are "weight loss shots" and "GLP-1" the same thing?

Mostly, yes — "weight loss shots" is everyday language, not a medical category. Semaglutide operates as a GLP-1 receptor agonist. Tirzepatide is a dual agonist for the GLP-1 and GIP receptors. Semaglutide is also available as oral tablets. The right form and medication are clinical decisions.

Is the "skinny shot" a real medication?

"Skinny shot" is slang, not a medical term — we avoid it because it oversells and understates the fact that these are real medications with real side effects.

Can I get GLP-1 pills instead of injections?

Semaglutide is available as oral tablets under the brand Rybelsus®, as well as subcutaneous injections such as Ozempic® and Wegovy®. Tirzepatide is not yet available in an oral form. Whether a pill or injection is suitable depends on your health profile and a clinician's assessment.

How fast do weight loss injections work?

There's no set timeline, and no guaranteed outcome. With semaglutide, achieving steady-state exposure typically occurs after several weeks of weekly administration[1], and the dose is escalated gradually. Individual results vary — anyone promising a specific number is overpromising.

Do I need a prescription to try one?

Yes. The FDA advises that patients should only obtain drugs containing semaglutide with a prescription from a licensed health care provider. A licensed clinician must evaluate you, screen for contraindications, and decide if treatment is appropriate before anything is prescribed.

How is compounded semaglutide different from a brand-name product?

Compounded medications are not FDA-approved, and they are a separate product from any commercially manufactured brand-name drug. They are prepared in FDA-regulated facilities by state-licensed pharmacies when a clinician determines it's appropriate. They should never be marketed as equivalent to a branded product.

Ladies First provides marketing/advertising services. Medical services are provided by our medical provider partner, an independent network of US-licensed medical providers. All medical decisions are made by a medical provider licensed in your state. This article is for general information and is not medical advice. Talk to a licensed medical provider about your situation. Individual results vary. Compounded medications are not FDA-approved. They are prepared in FDA-regulated facilities. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Use of these names is for identification only and does not imply affiliation or that any compounded preparation is equivalent to these products.

Sources & Evidence

  1. 1
    StatPearls (NCBI Bookshelf)
    “Semaglutide (mechanism, efficacy, adverse effects, contraindications) — Semaglutide - StatPearls - NCBI Bookshelf An official website of the United States government Here's how you know The .gov means it's official. Federal governme”
  2. 2
    WEGOVY (SEMAGLUTIDE)
    “FDA label, INDICATIONS AND USAGE”
  3. 3
    Zepbound (TIRZEPATIDE)
    “FDA label, INDICATIONS AND USAGE”
  4. 4
    StatPearls (NCBI Bookshelf)
    “Tirzepatide (mechanism, efficacy, adverse effects, contraindications) — Tirzepatide - StatPearls - NCBI Bookshelf An official website of the United States government Here's how you know The .gov means it's official. Federal governme”
  5. 5
    Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study. (Wu JY, Lee KW, Huang SC et al.
    “Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study. (Wu JY, Lee KW, Huang SC et al., 2026) · Effects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Tria”
Editorial standards. Ladies First content is written to be medically honest and independently sourced. A claim is only published once a primary source has been fetched and confirmed to support it; claims that cannot be independently verified are removed or routed for clinical sign-off. We describe process, not individuals.
The honest close every article here gets: whether any treatment is appropriate for you is a medical decision, made by a medical provider licensed in your state after reviewing your actual health history — not by an article. Finding out takes a few minutes, costs nothing, and you're never charged unless a provider approves your plan.

Free online consult · No payment until approval · 100% self-pay · Cancel any time

Ladies First is a women's telehealth marketing platform and does not provide medical services. All medical care is provided by our medical provider partner, an independent network of US-licensed medical providers; all medical decisions are made by a medical provider licensed in your state. Compounded medications are not FDA-approved; the FDA does not review compounded preparations for safety, effectiveness, or quality before they are marketed. They are prepared by state-licensed compounding pharmacies operating under USP <795> and/or USP <797> standards and are distinct from FDA-approved, brand-name products. These statements have not been evaluated to diagnose, treat, cure, or prevent any disease. Individual results vary and no outcome is promised. Treatment availability varies by state. 100% self-pay. This page is general information, not medical advice. Ozempic® and Wegovy® are trademarks of Novo Nordisk; Mounjaro® and Zepbound® are trademarks of Eli Lilly. AOD-9604, MOTS-C, and BPC-157 are not FDA-approved for weight loss.